Anavex Life Sciences Unveils Landmark Publication: Blarcamesine Heralds a New Era in Neurological Treatment
The Heartbreaking Truth: Unmasking Canine Distemper in Stumbling Strays, Not Always Rabies
A Crushing Blow: Acadia Pharma's Prader-Willi Syndrome Trial Fails to Meet Endpoints
Harmony Bio Faces Significant Setback: Fragile X Syndrome Therapy Misses Primary Endpoint in Pivotal Trial
A Beacon of Hope: uniQure's AMT-130 Gene Therapy Shines in Huntington's Disease Trial
Trump Reignites Debate: Is Tylenol Linked to Autism?
HIFU's Revolutionary Rise: A New Era in Non-Invasive Treatment Valued at $2.19 Billion by 2032
India Faces an Alzheimer's Epidemic: A Looming Crisis by 2036 That Demands Urgent Action
Beyond Forgetfulness: Unmasking Alzheimer's Hidden Warning Signs
Unpacking the Link: Gestational Diabetes and Neurodevelopmental Risks in Children
Unlocking Better Lives: How Early Questions Revolutionize Dementia Care
AI Unlocks the Mind: UCLA Brain Interface Deciphers User Intent, Not Just Commands
Unlocking Potential: Bright Minds Biosciences Poised for Growth Amidst Vast Patient Needs
Revolutionary Ultrasound Helmet Offers Non-Invasive Deep Brain Stimulation
Two Decades of Unwavering Hope: Saskatoon's Walk for Huntington's Disease Marks a Profound Milestone
Navigating the Path to Approval: Why REGENXBIO (RGNX) Remains a Strong Investment with RGX-121 for Hunter Syndrome
Urgent Warning: HHS Report Connects Pregnancy Tylenol Use to Autism Risk
Revolutionary Brain Map Reveals Decision-Making as a Distributed Neural Symphony
Unlocking the Neural Blueprint of Choice: Scientists Map Decision-Making in a Mammalian Brain
Revolutionizing Brain Health: How NeuroLink Diagnostics is Cracking the Code of Neurological Disease with AI
India's Unseen Epidemic: Decoding the Surge of Multiple Sclerosis and the Urgent Need for Action
Unlocking the Brain's Lifeline: How Connexin Proteins Orchestrate On-Demand Nourishment